Palliative care for caregivers should be initiated earlier rather than later
the ONA take:
A team of investigators, affiliated with University of Alabama at Birmingham, School of Nursing/Department of Medicine, examined the impact of early versus delayed intervention with regard to family caregivers for those with cancer.
For a period of slightly over 2 years, the researchers selected caregivers of patients with advanced cancer to receive intervention either soon after enrollment of 3 months afterward. Caregivers were recruited from a National Cancer Institute (NCI) cancer center, a Veterans Administration Medical Center, and two community outreach clinics. Intervention consisted of the following: three telephone coaching sessions per week, a monthly follow-up, and a bereavement call. One hundred twenty two caregivers participated in the study process.
Measured factors for caregivers in the two groups were depression, quality of life, and burden (objective, stress, and demand).
Data showed a lower rate of depression (both at the three-month mark and in terminal decline analysis) for the caregivers in the early group. The early intervention group also demonstrated lower stress burden, though quality of life was rated similar for both groups.
Study results were presented at the 50th Annual Meeting of the American Society of Clinical Oncology, in Chicago, Illinois.
The impact of early versus delayed intervention with regard to family caregivers for those with cancer.
- Osteoporosis Medication Improves Bone Health in ADT-Treated Prostate Cancer
- Coping With Lymphedema: A Patient Guide (Fact Sheet)
- Inotuzumab Ozogamicin Granted FDA Approval for Acute Lymphoblastic Leukemia
- Cabazitaxel in Prostate Cancer: Reduced Dose Noninferior to Standard Dose
- Risk of Some Cancers Higher in Women With a History of Periodontal Disease
- To Better Serve Patients With Cancer, Navigators Need Better Systems
- Physical Activity Improves Cognitive Function for Breast Cancer Survivors
- Risk of Lung Cancer Increases With Diets Higher in Saturated Fats
- Mechanisms Identified for Curcumin Resensitization of Cancer Cells
- Value of Type and Crossmatch Prior to Daratumumab Administration
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|